Skip to content
MarketScale
Demo
‹ Back to IndustriesHealthcare

HIMSS 2019: What People Are Saying

HIMSS 2019 is underway in Orlando, Florida, bringing together healthcare professionals from across the world. Social media is lighting up with some of the show’s best displays and we wanted to highlight the best of the best! If you’re at the show, make sure to read up on what you must check out this week…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

HIMSS 2019 is underway in Orlando, Florida, bringing together healthcare professionals from across the world.

Social media is lighting up with some of the show’s best displays and we wanted to highlight the best of the best!

If you’re at the show, make sure to read up on what you must check out this week in our event preview and interview with HIMSS Senior Director of Strategic Communications Karen Groppe!

The engagement started right away. It may not be breaking any barriers in the healthcare world but the opening reception area certainly got people excited:

This is great fun: #OpeningCeremony #reception #HIMMS19 now: “Magical“ Drinks, Networking, Party, Costumes! @HIMSS pic.twitter.com/rN8UDpzWBm
— MirjamBauer (@MirjamBauer) February 11, 2019

The #HIMSS2019 opening reception is underway!
There are some really cool superheroes here🦸. pic.twitter.com/BcjzKX2hxk
— Michael Johnson (@ghiafixer) February 11, 2019

Doors opened yesterday for the beginning of the expo. Attendees were welcomed to this massive show floor:

https://twitter.com/MichelleHostway/status/1095298346380656641

For some, it was too much to walk!

#HIMSS19 is huge. Here’s one way to efficiently get around. Bet he’s headed to Change Healthcare booth 3679. #HIMSS2019 #201901f pic.twitter.com/HgJIydf6T3
— Change Healthcare (@Change_HC) February 11, 2019

In terms of actual substance, there are plenty of sessions digging into the ways the industry is changing:

See how https://t.co/han7WxatBD can help you to convert and prepare medical data for 3D print very fast and easy. Visit us @DellEMCHealth Booth 3159 at #HIMSS19 @Intel @JNJCares #VR #TransformHIT #Aim2Innovate #3Dprint #dicom pic.twitter.com/h4UHo4BKQw
— Medicalholodeck (@medicalholodeck) February 12, 2019

Great session today on how AI can help deliver us smarter patient care. Amazing to see liked minded people from different parts of healthcare with one vision of improving our patients experience. @neilgomes @DICEGRP @TJUHospital #Engage4Health pic.twitter.com/KshPtTWYQL
— Viraj Patwardhan (@Viraj_says) February 11, 2019

Cybersecurity is a mission-critical concern for healthcare IT. @VMware’s own Dan Phoenix is hosting a #HIMSS19 session on “Intrinsic Security for Critical Healthcare Apps”: join us today @ 2:15 pm in Hall A, Booth 400, Cybersecurity Theater A: https://t.co/zdmjUXk5aT #HITSecurity
— Christopher Logan (@logancm77) February 12, 2019

Come ride with @Uber Health today at #HIMSS19 booth #5585. Just look up for our sign! Care begins with getting there and learn how @MedStarHealth and thousands of others are using Uber Health and our solutions already. #HIMSS2019 #SDoH pic.twitter.com/g2GuKs87j1
— Dan Trigub (@datrigub) February 12, 2019

Stay tuned for more coverage of the HIMSS 2019 conference all week and interact with us on social media!

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For Healthcare teams

See how Healthcare teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›Marketing Tech›
Keep exploring

More from Healthcare

Healthcare hubMore expert Healthcare coverage.Explore →Executive Thought LeadershipPut clinical leaders on the record.Explore →CooperVisionMedical device storytelling.Explore →State of GEO & AI VisibilityHow B2B brands get cited by AI search.Explore →

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512